Emerging Therapy Solutions

Private

Bloomington, MinnesotaHealthcare & Life Scienceshttps://emergingtherapies.com/

Last Round

Series C

Mar 26, 2024

Total Funding Raised

$8M

Company Overview

Emerging Therapy Solutions is a healthcare company that provides risk and cost management services for payers dealing with high-cost cell, gene, and transplant therapies.

Sector

Healthcare & Life Sciences

Verticals

InsurTech, Compliance & Risk, Healthcare Analytics, Patient Engagement

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

gene therapy managementcell therapy managementCGTspecialty pharmacy managementstop-loss insurancereinsurance supportcare navigationpayer servicesmedical benefit managementfinancial risk mitigationhigh-cost therapyhealthcare analyticsinsurtechmanaged carecatastrophic claims

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Emerging Therapy Solutions Comparables

Compare Emerging Therapy Solutions with similar companies based on industry and business-model similarity.

Emerging Therapy Solutions comparables — related companies by embedding similarity
Company	Similarity	Market Cap
CGT Solutions, LLC	80%
One80 Intermediaries	76%
August	74%

View all Comparables

Emerging Therapy Solutions Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series C	Mar 26, 2024
Series B	Dec 20, 2022
VC Round	Jun 7, 2021
VC Round	Feb 11, 2021
VC Round	Feb 4, 2020
VC Round	May 1, 2019

View all Funding Rounds

Key People

Founding team and executive leadership

Jamison Rohde

Chief Operating Officer

Executive Team

Emerging Therapy Solutions Investors

Notable investors and investment history

Emerging Therapy Solutions investors
Investor	Rounds
Telegraph Hill Partners	VC Round, Series B, Series C

View all Investors

Emerging Therapy Solutions Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Emerging Therapy Solutions Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Emerging Therapy Solutions's valuation, stock price, and market status.

Firmographic Details

HeadquartersBloomington, Minnesota

Employee Range32

Year Founded2018

Last FundingMar 26, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.